Arca Biopharma | ABIO - الربح الإجمالي على المبيعات





الربح الإجمالي على المبيعات تغيير تاريخ
Amgen USD 5.87B 1.02B 2026-03
Arca Biopharma 0 0 2025-03
Biogen USD 2.12B 307M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Capricor Therapeutics 11.13M 8.87M 2024-12
Cipla INR 44.1B 5B 2026-06
Clal Biotechnology ILS -857K 1.42M 2022-06
Compugen USD 352K 63.44M 2026-03
CSL USD 4.46B 2.71B 2025-12
Cytokinetics USD 23.03M 3.84M 2026-06
Daiichi Sankyo JPY 287.15B 152.68B 2026-03
Gilead Sciences USD 6.8B 1.29B 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
Grifols EUR 766.49M 39.74M 2024-12
Laboratory Of America USD 1.11B 98.2M 2026-06
Myriad Genetics USD 146.8M 3M 2025-12
Otsuka Holdings JPY 456.25B 1.16B 2026-03
Pfizer USD -248M 11.29B 2026-06
United Therapeutics USD 683.8M 35.7M 2026-06